Memphis Pharmaceutical & Chemical Industries (MPCI) Net Income
Net Income
EGP 518.28M
Trailing 12 months (TTM)
As of 23 Jul 2026, 19:29 (Cairo time)
Net income is the profit remaining after all operating costs, interest and taxes are deducted from revenue — the bottom line of the income statement. A negative figure means the company recorded a loss for that fiscal year.
Net income history
| Fiscal year | Net income | YoY growth | Net margin |
|---|---|---|---|
| 2025 | 505.28M | 163.91% | 33.51% |
| 2024 | 191.46M | 111.7% | 21.96% |
| 2023 | 90.44M | 22.07% | 13.62% |
| 2022 | 74.09M | 77.22% | 13.44% |
| 2021 | 41.81M | 140.14% | 8.07% |
| 2020 | 17.41M | 168.6% | 3.55% |
| 2019 | -25.38M | 45.7% | -6.92% |
| 2018 | -46.74M | -36.57% | -13.61% |
| 2017 | -34.22M | -38,711.62% | -13.68% |
| 2016 | 88,627 | 100.86% | 0.02% |
| 2015 | -10.28M | -562.37% | -2.59% |
| 2014 | 2.22M | -51.88% | 0.53% |
| 2013 | 4.62M | 342.33% | 1.16% |
| 2012 | 1.04M | -81.04% | 0.37% |
| 2011 | 5.51M | — | 1.57% |
| 2009 | 9.58M | — | 2.15% |
| 2006 | 26.05M | 14.31% | 14.96% |
| 2005 | 22.79M | — | 13.97% |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.